Medical Device Reimbursement for France

See all reimbursement consulting services.

Unlike the European Union’s medical device approval process, which is carried out in similar fashion by all member states, medical device reimbursement systems can vary significantly from region to region. The medical device reimbursement system in France is one of the EU’s most complex, but also one of the largest.

France Reimbursement Consulting Services

Several national- and local-level decision makers influence the French reimbursement process, including the French Health Ministry. Diagnosis-related groups (DRGs) fund the bulk of medical devices in France; add-on lists and funding through medical procedures cover the remainder.

Emergo Group consultants based in Europe have extensive experience dealing with the French health care system’s reimbursement requirements, and can ensure that you obtain the maximum level of reimbursement possible in France. Depending on the level of support you require for your reimbursement effort in the French medical device market, we offer the following services:

Reimbursement Roadmap for France

Emergo Group offers a Reimbursement Roadmap for clients less familiar with French reimbursement system requirements. Our Reimbursement Roadmap provides an overview of France’s medical device reimbursement process, including how national, regional and local authorities shape reimbursement schedules and rates. Four main components make up our Reimbursement Roadmap offering:

A general overview of the medical device reimbursement system in France
Recent and upcoming changes to the reimbursement system
Steps necessary to be properly reimbursed in France according to your product’s intended use
Recommendations for next steps

Reimbursement Assessment for France

Clients more familiar with France’s medical device reimbursement process can utilize our Reimbursement Assessment service to develop their reimbursement strategies for the French market. This service is tailored to match your specific business requirements, and provides tools such as:

Mapping current reimbursement schedules for specific procedures and treatments
Identifying existing codes and funding for devices similar to yours
Identifying processes and potential obstacles to reimbursement
Identifying key national and regional players influencing the reimbursement process for your device
Recommending short- and long-term reimbursement strategies in line with your French market penetration plans
Health Technology Assessment (HTA) reviews
Key Opinion Leader (KOL) interviews

Emergo Group’s European consultants have the expertise to successfully address French reimbursement system requirements on your behalf, in order to secure reimbursement for your device as quickly as possible.

Emergo Group can also provide literature reviews of French HTAs and other policies and procedures impacting the medical device reimbursement process in France. Under this service, we provide reviews of existing clinical literature that can be used to support your effort to obtain appropriate reimbursement by highlighting how the French system reimburses manufacturers of similar devices. In addition to France, Emergo Group can also support your reimbursement efforts in England, The Netherlands, Germany, Norway, Denmark and Sweden.